🔴 CALC is trading 8.1% down today as investors digest $49 million private placement

CALC is trading at $0.75 (8.1% down) in after-hours trading as investors digest the implications of a recently announced $49 million private placement.

• The financing provides the sub-dollar biotech firm with an extended cash runway but highlights concerns regarding shareholder dilution and execution risk.
• The current pullback appears to be a reversal of the stock's recent sharp rebound rather than a new company-specific shock.
• Shares remain volatile as the market balances the strengthened balance sheet against the immediate impact of the sizeable financing deal.